E nd-stage kidney disease (ESKD) is highly prevalent worldwide and is associated with high mortality, morbidity, and cost. It has been estimated that, in 2010, a total of 2.6 million people received kidney replacement therapy (KRT) globally, and that between 4.9 and 9.7 million patients needed KRT. For the Latin American and Caribbean regions, the number of patients receiving versus needing KRT was 373,000 versus 626,000. 1 Although a national dialysis registry is lacking in Mexico, in 2005, it was estimated that there were approximately 130,000 patients with ESKD and that only half of them had access to KRT. 2 Furthermore, the burden of disease attributed to chronic kidney disease (CKD) has increased dramatically. Among all diseases, CKD went from being ranked #16 in 1990 to #2 in 2013
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.